Exploration into methylene blue reveals mixed outcomes

An exploration into the use of methylene blue as a potential remedy for jet lag, sparked by RFK Jr's social media post.

Methylene blue shows potential for jet lag relief in new trial

In a recent article, a travel writer experimented with methylene blue as a way to combat jet lag during a trip from New York to Sydney. The interest in methylene blue was buoyed by footage of Health Secretary Robert F. Kennedy Jr using the blue substance on a flight. Methylene blue, a synthetic dye known for treating certain ailments, is gaining traction for its supposed health benefits, including cognitive support and anti-aging properties. The trial involved daily doses leading up to and throughout the journey, with the writer reporting feelings of energy and alertness. However, some side effects, such as taste loss and tingling sensations, were noted. Despite being illegal in Australia without a prescription, the trial raises curiosity about the dye’s potential as a travel aid.

The recent experimentation with methylene blue highlights a growing trend in travel wellness. While some advocate for its cognitive and physical benefits, such as improved oxygen function, the lack of FDA approval and limited scientific studies for jet lag specifically remain significant concerns. This trend could drive more travelers to explore non-traditional solutions, but the risks—side effects and legal restrictions—demand careful consideration. As interest mounts, it prompts a deeper look into how travelers approach health during their journeys and whether unregulated substances become commonplace in wellness routines.

Highlights

As travel continues to expand, the question remains whether traditional remedies can be replaced by emerging alternatives.